Company registration number 04773839 (England and Wales)
DALEACRE MEDICAL SERVICES LTD
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024
PAGES FOR FILING WITH REGISTRAR
DALEACRE MEDICAL SERVICES LTD
COMPANY INFORMATION
Directors
Mr I C Mckenzie
Mr D R Evans
Mrs J A W Evans
Company number
04773839
Registered office
11 Wilsthorpe Road
Breaston
Derby
Derbyshire
DE72 3EA
Auditor
Xeinadin Audit Ltd
i2 Mansfield, Office Suite 0.3
Hamilton Court
Oakham Business Park
Mansfield
Nottinghamshire
NG18 5FB
DALEACRE MEDICAL SERVICES LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
DALEACRE MEDICAL SERVICES LTD
BALANCE SHEET
AS AT
31 JULY 2024
31 July 2024
- 1 -
2024
2023
Notes
£
£
£
£
Current assets
Debtors
3
8
8
Net current assets
8
8
Capital and reserves
Called up share capital
4
1
1
Profit and loss reserves
7
7
Total equity
8
8

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 28 April 2025 and are signed on its behalf by:
Mr D R Evans
Mrs J A W Evans
Director
Director
Company registration number 04773839 (England and Wales)
DALEACRE MEDICAL SERVICES LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024
- 2 -
1
Accounting policies
Company information

Daleacre Medical Services Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 11 Wilsthorpe Road, Breaston, Derby, Derbyshire, DE72 3EA.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

Related party exemption

The company has taken advantage of exemption, under the terms of the Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' not to disclose related party transactions within the group.

 

The ultimate parent undertaking is Daleacre Holdings Limited and the results of the company are incorporated in its group accounts. The company is also incorporated in England and Wales, its registered office is 11 Wilsthorpe Road, Breaston, Derby, DE72 3EA.

1.2
Going concern

For reasons of operational efficiency, the directors have agreed to transfer the trade of the company into a fellow Group company, Daleacre Healthcare Ltd, and the company ceased to trade on 31th July 2020. The directors do not consider that any adjustments will be required to the carrying value of the company's assets or any provision required as a result of the company ceasing to be a going concern.

1.3
Profit and loss account

The company has not traded during the year or the preceding financial period. During this time, the company received no income and incurred no expenditure and therefore no Profit and loss account is presented in these financial statements.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

 

Debtors and creditors receivable/payable with a year

Debtors and creditors are recorded at transaction price receivable or payable within one year. Any losses arising from impairment are recognised in the profit and loss account within administrative expenses.

1.6
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

DALEACRE MEDICAL SERVICES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2024
- 3 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
-
0
-
0
3
Debtors
2024
2023
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
8
8
4
Called up share capital
2024
2023
Ordinary share capital
£
£
Issued and fully paid
Ordinary shares of £1 each
1
1
5
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006:

The auditor's report was unqualified.

Senior Statutory Auditor:
Russell Eley FCCA
Statutory Auditor:
Xeinadin Audit Ltd
Date of audit report:
29 April 2025
2024-07-312023-08-01true29 April 2025CCH SoftwareCCH Accounts Production 2024.100No description of principal activityThis audit opinion is unqualifiedMr I C MckenzieMr D R EvansMrs J A W Evansfalsefalse047738392023-08-012024-07-3104773839bus:Director12023-08-012024-07-3104773839bus:Director22023-08-012024-07-3104773839bus:Director32023-08-012024-07-3104773839bus:RegisteredOffice2023-08-012024-07-31047738392024-07-31047738392023-07-3104773839core:ShareCapital2024-07-3104773839core:ShareCapital2023-07-3104773839core:RetainedEarningsAccumulatedLosses2024-07-3104773839core:RetainedEarningsAccumulatedLosses2023-07-31047738392022-08-012023-07-3104773839core:CurrentFinancialInstruments2024-07-3104773839core:CurrentFinancialInstruments2023-07-3104773839bus:EntityNoLongerTradingButTradedInPast2023-08-012024-07-3104773839bus:PrivateLimitedCompanyLtd2023-08-012024-07-3104773839bus:SmallCompaniesRegimeForAccounts2023-08-012024-07-3104773839bus:FRS1022023-08-012024-07-3104773839bus:Audited2023-08-012024-07-3104773839bus:FullAccounts2023-08-012024-07-31xbrli:purexbrli:sharesiso4217:GBP